| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/07/2011 | CN102176909A 2-hydroxy-ethanesulfonate salt |
| 09/07/2011 | CN102174090A Swine-origin influenza A virus head protein and preparation method and application thereof |
| 09/07/2011 | CN102174089A Avian influenza virus head protein as well as preparation method and application thereof |
| 09/07/2011 | CN102174046A Tetomilast polymorphs |
| 09/07/2011 | CN102174045A Tetomilast polymorphs |
| 09/07/2011 | CN102174044A Tetomilast polymorphs |
| 09/07/2011 | CN102174024A 2,4-pyrimidinediamine compounds and their uses |
| 09/07/2011 | CN102172386A Eupatorium clenbuterol preparation capable of preventing and treating respiratory diseases of livestock and poultry and production technique thereof |
| 09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
| 09/07/2011 | CN101912595B Ginger-bile medicament for treating cough and asthma |
| 09/07/2011 | CN101716232B Quality control method of throat clearing dropping pill |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101584852B Pharmaceutical preparation for getting rid of phlegm and retained fluid |
| 09/07/2011 | CN101496869B Chinese medicine preparation for treating bronchitis |
| 09/07/2011 | CN101418334B Diterpenes diterpenoids natural product inhibitor for main protease of coronaviruses such as SARS and screen method thereof |
| 09/07/2011 | CN101347612B Compound medicament for treating common cold cough and acute/chronic bronchitis, and preparation method thereof |
| 09/07/2011 | CN101342333B Traditional Chinese medicine for treating cough and asthma and preparation method thereof |
| 09/07/2011 | CN101332269B Traditional Chinese medicine propellant for treating pharyngitis and preparation method thereof |
| 09/07/2011 | CN101317824B Levodropropizine lozenge and preparation method thereof |
| 09/07/2011 | CN101278981B Medicament for treating upper respiratory tract infection in children and preparation method thereof |
| 09/07/2011 | CN101259242B Medicine for treating allergic rhinitis |
| 09/07/2011 | CN101234139B Proprietary Chinese medicine for curing common cold and preparation thereof |
| 09/07/2011 | CN101203493B Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012964 9-substituted 8-oxoadenine compound |
| 09/06/2011 | US8012959 Diaminopyrimidinecarboxamide derivative |
| 09/06/2011 | US8012934 Small peptides and methods for treatment of inflammation |
| 09/06/2011 | US8012508 Method of targeting sustained release formulations of therapeutic agents to treat lung diseases |
| 09/06/2011 | US8012504 Sustained release portion of unit dose containing guaifenesin, dextromethorphan and a release-delaying matrix contains a hydrophilic polymer and a water insoluble polymer, immediate release portion containing guaifenesin |
| 09/06/2011 | CA2495454C Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2457983C Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
| 09/06/2011 | CA2449419C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/01/2011 | WO2011105975A1 Dry powder formulations administered by the inhalation route comprising a combination of tiotropium bromide, salmeterol xynafoate and fluticasone propionate. |
| 09/01/2011 | WO2011105539A1 Coated solid preparation |
| 09/01/2011 | WO2011104621A1 Surfactant composition |
| 09/01/2011 | WO2011104584A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | WO2011103774A1 Pharmaceutical composition and use thereof in manufacturing medicaments for treating respiratory diseases |
| 09/01/2011 | WO2011103715A1 Task channel antagonists |
| 09/01/2011 | WO2011041639A3 Heteroatom containing substituted fatty acids |
| 09/01/2011 | WO2011015882A3 Anhydrate of triotropium bromide |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213023 Method for inhibiting production of cytokines of t helper cell type ii and/or inhibiting production of chemokines using brazilin |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212998 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 09/01/2011 | US20110212992 Novel p2x7r antagonists and their use |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212960 New compounds for the treatment of cns disorder |
| 09/01/2011 | US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212944 2-oxo-1-pyrrolidine derivatives |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212912 Optimised formulation of tobramycin for aerosolization |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212883 Radical scavenger and active oxygen eliminating agent |
| 09/01/2011 | US20110212181 Compositions and methods for treating chronic respiratory inflammation |
| 09/01/2011 | US20110212175 Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212137 Inhalable pharmaceutical composition |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212087 Antibody Fc Mutants with Ablated Effector Functions |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110209699 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 09/01/2011 | CA2790993A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | CA2785694A1 Coated solid montelukast preparation |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361243A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 08/31/2011 | EP2231676B1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo-[a,d]-cyclohepten-5-ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis |
| 08/31/2011 | EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases |
| 08/31/2011 | EP2183027B1 Organic compounds |
| 08/31/2011 | EP2117553B1 Compositions for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory track |
| 08/31/2011 | EP2018395B1 Short interference ribonucleic acids for treating allegic diseases |
| 08/31/2011 | EP1568688B1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
| 08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
| 08/31/2011 | CN102170864A Respiratory disease treatment |
| 08/31/2011 | CN102168062A Human pulmonary artery smooth muscle cell separation and culturing method and application of same |
| 08/31/2011 | CN102167745A Human monoclonal antibody against IgE, preparation method and purpose thereof |
| 08/31/2011 | CN102166319A Soup for treating wind cold |
| 08/31/2011 | CN102166314A Oil in water type citionella oil nanoemulsion and preparation method thereof |
| 08/31/2011 | CN102166300A Traditional Chinese medicine preparation for treating pulmonary yin deficiency, gastric yin deficiency and diabetic yin deficiency |
| 08/31/2011 | CN102166298A Chronic pharyngitis preparation |
| 08/31/2011 | CN102166296A Medicine for treating bronchitis and asthma and preparation method thereof |
| 08/31/2011 | CN102166294A Common anemarrhena polysaccharide extractive and preparation method and medicinal purposes thereof |
| 08/31/2011 | CN102166287A Recovery mud moxibustion and preparation method |
| 08/31/2011 | CN102166282A Anti-allergic or desensitized pharmaceutical composition |